SG10201801415TA - Lens incorporating myopia control optics and muscarinic agents - Google Patents

Lens incorporating myopia control optics and muscarinic agents

Info

Publication number
SG10201801415TA
SG10201801415TA SG10201801415TA SG10201801415TA SG10201801415TA SG 10201801415T A SG10201801415T A SG 10201801415TA SG 10201801415T A SG10201801415T A SG 10201801415TA SG 10201801415T A SG10201801415T A SG 10201801415TA SG 10201801415T A SG10201801415T A SG 10201801415TA
Authority
SG
Singapore
Prior art keywords
muscarinic agents
myopia control
control optics
lens incorporating
incorporating myopia
Prior art date
Application number
SG10201801415TA
Inventor
Chehab Khaled
H Shedden Arthur Jr
Cheng Xu
Original Assignee
Johnson & Johnson Vision Care
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johnson & Johnson Vision Care filed Critical Johnson & Johnson Vision Care
Publication of SG10201801415TA publication Critical patent/SG10201801415TA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/10—Ophthalmic agents for accommodation disorders, e.g. myopia
    • G—PHYSICS
    • G02—OPTICS
    • G02C—SPECTACLES; SUNGLASSES OR GOGGLES INSOFAR AS THEY HAVE THE SAME FEATURES AS SPECTACLES; CONTACT LENSES
    • G02C7/00—Optical parts
    • G02C7/02—Lenses; Lens systems ; Methods of designing lenses
    • G02C7/04—Contact lenses for the eyes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00—Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • A61F9/0008—Introducing ophthalmic products into the ocular cavity or retaining products therein
    • A61F9/0017—Introducing ophthalmic products into the ocular cavity or retaining products therein implantable in, or in contact with, the eye, e.g. ocular inserts
    • G—PHYSICS
    • G02—OPTICS
    • G02C—SPECTACLES; SUNGLASSES OR GOGGLES INSOFAR AS THEY HAVE THE SAME FEATURES AS SPECTACLES; CONTACT LENSES
    • G02C2202/00—Generic optical aspects applicable to one or more of the subgroups of G02C7/00
    • G02C2202/24—Myopia progression prevention
    • G—PHYSICS
    • G02—OPTICS
    • G02C—SPECTACLES; SUNGLASSES OR GOGGLES INSOFAR AS THEY HAVE THE SAME FEATURES AS SPECTACLES; CONTACT LENSES
    • G02C7/00—Optical parts
    • G02C7/02—Lenses; Lens systems ; Methods of designing lenses
    • G02C7/04—Contact lenses for the eyes
    • G02C7/041—Contact lenses for the eyes bifocal; multifocal

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Epidemiology (AREA)
  • Optics & Photonics (AREA)
  • General Physics & Mathematics (AREA)
  • Emergency Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Eyeglasses (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SG10201801415TA 2012-07-31 2013-07-25 Lens incorporating myopia control optics and muscarinic agents SG10201801415TA (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US13/563,322 US9827250B2 (en) 2012-07-31 2012-07-31 Lens incorporating myopia control optics and muscarinic agents

Publications (1)

Publication Number Publication Date
SG10201801415TA true SG10201801415TA (en) 2018-03-28

Family

ID=48875618

Family Applications (2)

Application Number Title Priority Date Filing Date
SG2013056866A SG196752A1 (en) 2012-07-31 2013-07-25 Lens incorporating myopia control optics and muscarinic agents
SG10201801415TA SG10201801415TA (en) 2012-07-31 2013-07-25 Lens incorporating myopia control optics and muscarinic agents

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SG2013056866A SG196752A1 (en) 2012-07-31 2013-07-25 Lens incorporating myopia control optics and muscarinic agents

Country Status (11)

Country Link
US (1) US9827250B2 (en)
EP (1) EP2693259B1 (en)
JP (4) JP2014032404A (en)
KR (1) KR102046303B1 (en)
CN (1) CN103576337B (en)
AU (1) AU2013211446B2 (en)
BR (1) BR102013019429A2 (en)
CA (1) CA2822461C (en)
RU (1) RU2560206C2 (en)
SG (2) SG196752A1 (en)
TW (1) TWI597069B (en)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10413506B2 (en) 2010-04-03 2019-09-17 Praful Doshi Medical devices including medicaments and methods of making and using same including enhancing comfort, enhancing drug penetration, and treatment of myopia
TWI588560B (en) 2012-04-05 2017-06-21 布萊恩荷登視覺協會 Lenses, devices, methods and systems for refractive error
US9201250B2 (en) 2012-10-17 2015-12-01 Brien Holden Vision Institute Lenses, devices, methods and systems for refractive error
MY179138A (en) 2012-10-17 2020-10-28 Holden Brien Vision Inst Lenses, devices, methods and systems for refractive error
WO2014102829A1 (en) * 2012-12-31 2014-07-03 Mylan Laboratories Ltd. Crystalline atropine sulfate
CN105555363B (en) 2013-05-06 2019-03-12 长庚医疗财团法人高雄长庚纪念医院 Medical component and application thereof
WO2016172712A2 (en) 2015-04-23 2016-10-27 Sydnexis, Inc. Ophthalmic composition
US9421199B2 (en) * 2014-06-24 2016-08-23 Sydnexis, Inc. Ophthalmic composition
US11382909B2 (en) 2014-09-05 2022-07-12 Sydnexis, Inc. Ophthalmic composition
JP5923640B1 (en) * 2015-04-13 2016-05-24 国立大学法人大阪大学 Method for designing and manufacturing contact lens for suppressing myopia progression
US10010502B2 (en) * 2015-05-19 2018-07-03 Amorphex Therapeutics Llc Device that delivers a sustained low-dose of a myopia-suppressing drug, while preserving pupillary function and accommodation
CN107847432A (en) 2015-05-29 2018-03-27 西德奈克西斯公司 D2The stabilized pharmaceutical preparations of O
KR102336448B1 (en) * 2015-06-10 2021-12-07 삼성전자주식회사 Electronic apparatus and method for photograph extraction
CN110320676A (en) 2015-09-15 2019-10-11 星欧光学股份有限公司 Contact lens products
US10371964B2 (en) 2015-09-15 2019-08-06 Largan Medical Co., Ltd. Contact lens product
TWI780873B (en) 2015-09-15 2022-10-11 星歐光學股份有限公司 Contact lens product
US10845622B2 (en) * 2015-09-15 2020-11-24 Largan Medical Co., Ltd. Multifocal contact lens and contact lens product
TWI702438B (en) * 2015-10-29 2020-08-21 星歐光學股份有限公司 Contact lens product
JP2017080303A (en) * 2015-10-30 2017-05-18 日油株式会社 Medicine sustained release medical use contact lens
TWI588562B (en) * 2015-12-31 2017-06-21 星歐光學股份有限公司 Contact lens
TWI587034B (en) * 2016-02-04 2017-06-11 星歐光學股份有限公司 Contact lens product
KR102578476B1 (en) 2016-04-11 2023-09-13 유니버시티 오브 캔버라 Ophthalmic compositions comprising levodopa, an antioxidant and an aqueous carrier
TWI639028B (en) * 2016-09-02 2018-10-21 星歐光學股份有限公司 Contact lens product
TWI641892B (en) * 2016-09-30 2018-11-21 星歐光學股份有限公司 Contact lens and contact lens product
KR20180116574A (en) * 2017-04-17 2018-10-25 엘지전자 주식회사 Mobile terminal
US10698232B2 (en) * 2017-06-23 2020-06-30 Largan Medical Co., Ltd. Contact lens and product thereof
JP2019020730A (en) * 2017-07-13 2019-02-07 ロート製薬株式会社 Multifocal soft contact lens
TWI822690B (en) 2017-07-20 2023-11-21 中國大陸商盛元醫藥廣州有限公司 Compositions and methods for treatment of myopia
AU2018371787A1 (en) 2017-11-21 2020-11-05 Sydnexis, Inc. Ophthalmic composition and delivery device thereof
IT201800005599A1 (en) * 2018-05-22 2019-11-22 Soft contact lens
US11209670B2 (en) * 2019-05-08 2021-12-28 Johnson & Johnson Vision Care, Inc Method for designing edge to edge photochromic soft contact lenses
US11092822B2 (en) * 2019-05-08 2021-08-17 Johnson & Johnson Vision Care, Inc. Photochromic soft contact lens with cosmetic and efficacy considerations
US11071724B2 (en) * 2019-05-17 2021-07-27 Ocular Science, Inc. Compositions and methods for treating presbyopia
AU2020290414A1 (en) * 2019-06-10 2021-12-02 Jenivision Inc. Methods and formulations for treating vision disorders
US20230134059A1 (en) * 2020-03-11 2023-05-04 Brien Holden Vision Institute Limited Ophthalmic lenses and methods for correcting, slowing, reducing, and/or controlling the progression of myopia in conjunction with use of atropine or related compounds
IL298796A (en) * 2020-06-02 2023-02-01 Univ Columbia Methods and compositions for preventing and treating myopia with levocabastine, a selective histamine h1-receptor antagonist, and derivatives thereof
IL298974A (en) * 2020-06-11 2023-02-01 Univ Columbia METHODS AND COMPOSITIONS FOR PREVENTING AND TREATING MYOPIA WITH FENOTEROL HYDROBROMIDE, A β2- ADRENERGIC RECEPTOR AGONIST, AND DERIVATIVES THEREOF
EP4164606A1 (en) * 2020-06-11 2023-04-19 The Trustees Of Columbia University In The City Of New York Methods and compositions for preventing and treating myopia with trichostatin a, a histone deacetylase (hdac) inhibitor, and derivatives thereof
CA3182431A1 (en) * 2020-06-11 2021-12-16 Andrei V. Tkatchenko Methods and compositions for preventing and treating myopia with fingolimod, a sphingosine-1-phosphate receptor modulator, and derivatives thereof

Family Cites Families (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3901967A (en) * 1973-09-10 1975-08-26 Union Corp Sustained release of atropine
SU977466A1 (en) * 1979-11-06 1982-11-30 Киевский Ордена Трудового Красного Знамени Медицинский Институт Им.Акад.А.А.Богомольца Polyacrylamide gel for medical and biological uses and process for producing the ssame
US4668506A (en) 1985-08-16 1987-05-26 Bausch & Lomb Incorporated Sustained-release formulation containing and amino acid polymer
CA1295941C (en) 1985-08-16 1992-02-18 Rajan Bawa Sustained-release formulation comprising a hydrophobic polymer system
JPH0429215A (en) * 1990-05-25 1992-01-31 Nippon Telegr & Teleph Corp <Ntt> Contact lens with color discriminating function and its production
WO1993013777A1 (en) 1992-01-21 1993-07-22 Merck & Co., Inc. Method of using m1-selective antimuscarinic pyridobenzodiazepinones in axial myopia therapy
US5448312A (en) 1992-12-09 1995-09-05 Johnson & Johnson Vision Products, Inc. Pupil-tuned multifocal ophthalmic lens
US5691323A (en) * 1995-05-12 1997-11-25 Merck & Co., Inc. Muscarine antagonists
US6045578A (en) 1995-11-28 2000-04-04 Queensland University Of Technology Optical treatment method
US5952338A (en) 1996-07-05 1999-09-14 Takeda Chemical Industries, Ltd. Agent for prophylaxis and treatment of disturbance of visual function
US6822016B2 (en) * 2001-09-10 2004-11-23 Johnson & Johnson Vision Care, Inc. Biomedical devices containing internal wetting agents
ATE324091T1 (en) * 1999-12-06 2006-05-15 Thomas Faxe DEVICE FOR ATTACHING, REMOVING AND STORING CONTACT LENSES
CN2430714Y (en) 1999-12-20 2001-05-16 程杰 Artificial iris glasses
WO2002040994A2 (en) * 2000-11-14 2002-05-23 Yissum Research Development Company Of The Hebrew University Of Jerusalem System and method for assaying drugs
US20080194481A1 (en) * 2001-12-21 2008-08-14 Human Genome Sciences, Inc. Albumin Fusion Proteins
US20060100408A1 (en) 2002-03-11 2006-05-11 Powell P M Method for forming contact lenses comprising therapeutic agents
CA2479351C (en) 2002-03-18 2012-05-15 Novartis Ag Topical composition comprising a cyclofructan, a carrier and a drug
US20050255144A1 (en) 2003-04-09 2005-11-17 Directcontact Llc Methods and articles for the delivery of medicaments to the eye for the treatment of posterior segment diseases
US20050208102A1 (en) 2003-04-09 2005-09-22 Schultz Clyde L Hydrogels used to deliver medicaments to the eye for the treatment of posterior segment diseases
US20050074497A1 (en) 2003-04-09 2005-04-07 Schultz Clyde L. Hydrogels used to deliver medicaments to the eye for the treatment of posterior segment diseases
JP4812268B2 (en) * 2004-08-03 2011-11-09 リンテック株式会社 Volatilization inhibitor, volatile component-containing composition and patch
CA2597219C (en) 2005-02-04 2014-04-15 Auburn University Contact drug delivery system
US8349352B2 (en) 2005-02-04 2013-01-08 Auburn University Therapeutic contact lenses with anti-fungal delivery
TWI410696B (en) * 2005-02-15 2013-10-01 Univ Queensland Lens control of myopla
US9804295B2 (en) * 2005-05-05 2017-10-31 Novartis Ag Ophthalmic devices for sustained delivery of active compounds
US8440217B1 (en) * 2005-06-15 2013-05-14 Mawaheb M. EL-Naggar Method and system with contact lens product for treating and preventing adverse eye conditions
RU2351305C2 (en) * 2006-03-03 2009-04-10 Наталья Викторовна Киреева Method of prevention and treatment of acquired myopia
US20070254914A1 (en) * 2006-05-01 2007-11-01 Non-Profit Organization Chang Gung Memorial Hospital Low-concentration atropine solution for preventing myopia progression and preparing method thereof
CA2667781C (en) * 2006-10-30 2015-12-01 Novartis Ag Method for applying a coating onto a silicone hydrogel lens
US7793535B2 (en) 2006-10-31 2010-09-14 Johnson & Johnson Vision Care, Inc. Devices and methods to simulate an ocular environment
WO2008060574A2 (en) 2006-11-13 2008-05-22 Auburn University Therapeutic contact lenses with anti-fungal delivery
US20080138408A1 (en) * 2006-11-13 2008-06-12 Siddharth Venkatesh Drug delivery system and method
US8969415B2 (en) * 2006-12-01 2015-03-03 Allergan, Inc. Intraocular drug delivery systems
EP2097044A4 (en) * 2006-12-26 2012-10-10 Quadra Logic Tech Inc Drug delivery implants for inhibition of optical defects
US8690319B2 (en) 2007-05-21 2014-04-08 Johnson & Johnson Vision Care, Inc. Ophthalmic lenses for prevention of myopia progression
US7637612B2 (en) 2007-05-21 2009-12-29 Johnson & Johnson Vision Care, Inc. Ophthalmic lenses for prevention of myopia progression
US7931369B2 (en) * 2007-07-13 2011-04-26 David Andrew Harris Tinted lens and method of making same
US7625086B2 (en) 2007-08-28 2009-12-01 Johnson & Johnson Vision Care, Inc. Method of designing multifocal contact lenses
SG151148A1 (en) 2007-10-05 2009-04-30 Singapore Health Services Pte Method and/or kit for determining response to muscarinic receptor antagonist treatment
JP5401043B2 (en) 2007-11-09 2014-01-29 ロート製薬株式会社 Ophthalmic composition
US20110046033A1 (en) * 2008-01-31 2011-02-24 Jinzhong Zhang Multipurpose Lens Care Solution with Benefits to Corneal Epithelial Barrier Function
EP2285364B1 (en) * 2008-05-07 2015-01-21 The Regents of The University of California Therapeutic replenishment and enrichment of ocular surface lubrication
AU2009256266B2 (en) 2008-06-06 2015-04-09 Global-Ok Vision, Inc. Soft contact lenses for treating ametropia
CN100596332C (en) 2008-08-20 2010-03-31 东南大学 Medicine-carrying contact lens and preparation method thereof
AU2009325061B2 (en) * 2008-12-11 2014-05-29 Children's Medical Center Corporation Contact lens drug delivery device
US8883214B2 (en) 2009-01-13 2014-11-11 The Regents Of The University Of California Implantable delivery vehicle for ocular delivery of muscarinic antagonists
SG173069A1 (en) * 2009-01-23 2011-08-29 Quadra Logic Tech Inc Sustained released delivery of one or more agents
US8960901B2 (en) 2009-02-02 2015-02-24 Johnson & Johnson Vision Care, Inc. Myopia control ophthalmic lenses
CN102483526B (en) 2009-06-25 2013-11-13 庄臣及庄臣视力保护公司 Design of myopia control ophthalmic lenses
US9492272B2 (en) * 2009-08-13 2016-11-15 Acufocus, Inc. Masked intraocular implants and lenses
US8697770B2 (en) * 2010-04-13 2014-04-15 Johnson & Johnson Vision Care, Inc. Pupil-only photochromic contact lenses displaying desirable optics and comfort
US9690115B2 (en) * 2010-04-13 2017-06-27 Johnson & Johnson Vision Care, Inc. Contact lenses displaying reduced indoor glare
JP4768075B1 (en) * 2010-08-25 2011-09-07 博紀 藤田 Vision correction contact lens kit
US9046699B2 (en) 2012-03-13 2015-06-02 Johnson & Johnson Vision Care, Inc. Dynamic fluid zones in contact lenses
EP3075800B1 (en) 2013-11-29 2018-01-31 Panasonic Intellectual Property Management Co., Ltd. Coating material composition, and light-diffusing member manufactured using said coating material composition

Also Published As

Publication number Publication date
TWI597069B (en) 2017-09-01
RU2560206C2 (en) 2015-08-20
CN103576337A (en) 2014-02-12
CN103576337B (en) 2018-01-19
AU2013211446A1 (en) 2014-02-20
EP2693259B1 (en) 2018-02-21
BR102013019429A2 (en) 2015-07-14
CA2822461A1 (en) 2014-01-31
JP2020024433A (en) 2020-02-13
JP6980732B2 (en) 2021-12-15
US9827250B2 (en) 2017-11-28
RU2013135765A (en) 2015-02-10
JP2014032404A (en) 2014-02-20
TW201410265A (en) 2014-03-16
AU2013211446B2 (en) 2018-01-18
EP2693259A1 (en) 2014-02-05
SG196752A1 (en) 2014-02-13
KR102046303B1 (en) 2019-11-19
KR20140016851A (en) 2014-02-10
JP7192073B2 (en) 2022-12-19
JP2018132784A (en) 2018-08-23
CA2822461C (en) 2020-07-28
US20140036225A1 (en) 2014-02-06
JP2022003412A (en) 2022-01-11

Similar Documents

Publication Publication Date Title
SG10201801415TA (en) Lens incorporating myopia control optics and muscarinic agents
IL235663A0 (en) Ophthalmic lens
HK1205269A1 (en) Energized ophthalmic lens including stacked integrated components
HK1201933A1 (en) Lens for myopic eye
HK1209849A1 (en) Variable focus electroactive ophthalmic device
EP2883105A4 (en) Fail-safe electro-active lenses and methodology for choosing optical materials for fail-safe electro-active lenses
BR112015002548A2 (en) eye mask
EP2937724A4 (en) Cemented lens and lens unit
SI2914227T1 (en) Combined ophthalmic laser device
ZA201300548B (en) Nano-optic refractive optics
FR2996930B1 (en) PHOTOCHROMIC OPHTHALMIC LENS
HUE059395T2 (en) Intraocular lens
EP2851731A4 (en) Aberration correction device and laser microscope
EP2937730A4 (en) Spectacle lenses
PL2645154T3 (en) Procedure for designing a spectacle lens and spectacle lens
EP2902815A4 (en) Spectacle lens
HK1200109A1 (en) Ophthalmic composition
HK1200113A1 (en) Ophthalmic composition
FR2990774B1 (en) OPHTHALMIC LENS
HK1209491A1 (en) Antimicrobial ophthalmic contact lenses
EP2885671A4 (en) Low light vision assistance
HK1204455A1 (en) Disinfecting ophthalmic lenses
EP2934810A4 (en) Laser optics with lateral and angular shift-compensation
GB2501562B (en) Sliding lens spectacles
FR2996316B1 (en) PROGRESSIVE OPHTHALMIC LENS FOR PATIENT WITH VISUAL DEFICIENCY